The Gross Margin of Jafron Biomedical Co Ltd (300529.SZ) is 79.95%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 79.95% |
| 2022-12-31 | 82.32% |
| 2021-12-31 | 84.97% |
| 2020-12-31 | 85.24% |
| 2019-12-31 | 86.21% |
| 2018-12-31 | 84.80% |
| 2017-12-31 | 84.15% |
| 2016-12-31 | 83.92% |
| 2015-12-31 | 84.54% |
| 2014-12-31 | 84.71% |